Skip to content
Wenlo
Sign in
← Markets

United Therapeutics Corporation

United Therapeutics Corporation (UTHR) — Form 144: Proposed sale of shares

144UTHRFiled Nov 19, 2026, 4:38 PM ET

AI-generated summary

Officer PAUL MAHON filed to propose selling 8,300 shares of Common stock with an aggregate market value of $4,690,228.74 through Morgan Stanley Smith Barney LLC Executive Financial Services, acquired via a stock option exercise on November 19, 2026. The proposed sale is associated with a trading plan adopted on August 11, 2025.

Key facts

Seller
PAUL MAHON
Relationship
Officer
Shares to sell
8,300
Market value
$4,690,228.74
Approximate sale date
Nov 19, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired
Nov 19, 2026 · Stock Option Exercise

Rule 10b5-1 plan · adopted Aug 11, 2025

More UTHR filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.